Clinical Trials · NCT02420262
A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) Versus Basal-bolus Therapy in Subjects With Type 2 Diabetes Mellitus
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 506
- Start date
- Jul 2015
- Locations
- 117 sites, 12 countries
- Primary endpoint
- Change in HbA1c (Glycosylated Haemoglobin)